quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:15:40·1632d
INSIDERFiling
Eyegate Pharmaceuticals, Inc. logo

SEC Form 4: Romano Sarah covered exercise/tax liability with 83 shares, decreasing direct ownership by 0.36% to 23,059 units

EYEG· Eyegate Pharmaceuticals, Inc.
Health Care
Original source

Companies

  • EYEG
    Eyegate Pharmaceuticals, Inc.
    Health Care

Recent analyst ratings

  • Aug 16UpdateHC Wainwright & Co.$11.00

Related

  • PR862d
    AllianceBernstein Launches Five New Active ETFs
  • SEC1620d
    SEC Form 10-Q filed by Eyegate Pharmaceuticals, Inc.
  • INSIDER1625d
    SEC Form 4 filed by Daniels Eric Joseph
  • INSIDER1625d
    SEC Form 3 filed by new insider Daniels Eric Joseph
  • SEC1627d
    Eyegate Pharmaceuticals, Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
  • PR1627d
    EyeGate is Now Kiora Pharmaceuticals; Provides Update on Company's Sharpened Clinical Development Strategy
  • SEC1631d
    SEC Form D filed by Eyegate Pharmaceuticals, Inc.
  • INSIDER1632d
    SEC Form 4: From Stephen covered exercise/tax liability with 250 shares, decreasing direct ownership by 0.36% to 68,292 units
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022